Urinary Tract Infection Clinical Trial
— MUCHOfficial title:
When is the Best Moment to Remove the Urinary Catheter After Laparoscopic Hysterectomy: MUCH Study.
Verified date | August 2017 |
Source | Leiden University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Objective: The aim of this study is to evaluate if direct removal of the urine catheter after
an laparoscopic hysterectomy (total laparoscopic hysterectomy and laparoscopic supracervical
hysterectomy) is associated with similar (or better) outcomes compared to delayed catheter
removal after surgery, which is the current treatment. In addition, we want to investigate
patient's experience on this subject.
Study design: Randomized Controlled trial, non-inferiority study.
Study population: Women older than 18 years old, who are a laparoscopic hysterectomy for
benign indication or low-grade malignancy.
Intervention:
- Group A (treatment group): the patients in this group will have their catheter directly
removed in the OR after LH.
- Group B (control group): the patients in the control group will have their catheter
removed according to the regular protocol of the hospital (at least 6 hours in place).
Status | Completed |
Enrollment | 162 |
Est. completion date | June 21, 2017 |
Est. primary completion date | June 21, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Older than 18 years - Scheduled for LH for benign indication or low-grade malignancy (with or without salpingo-oophorectomy) Exclusion Criteria: - Concomitant procedures such as prolapse surgery, severe endometrioses and/or bowel resection - Preoperative known urinary voiding problems (incontinence) - Preoperative known urinary tract infection - Patients suffering from diseases potentially associated with inability to void (e.g. MS) - A Gravid or postpartum hysterectomy |
Country | Name | City | State |
---|---|---|---|
Netherlands | Reinier de Graaf Groep | Delft | |
Netherlands | Groene Hart Ziekenhuis | Gouda | |
Netherlands | Alrijne Hospital | Leiden | |
Netherlands | Leiden University Medical Center | Leiden | Noord-Holland |
Netherlands | Bronovo Hospital | The Hague | |
Netherlands | Haga Hospital | the Hague | |
Netherlands | Medisch Centrum Haaglanden | the Hague |
Lead Sponsor | Collaborator |
---|---|
Leiden University Medical Center | Alrijne Hospital, Bronovo Hospital, Groene Hart Ziekenhuis, Haga Hospital, Medical Center Haaglanden, Reinier de Graaf Groep |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Urinary retention (inability to void) | 6 hours after removal of urinary catheter | ||
Secondary | Rate of re-catheterisation | 6 hours without voiding | ||
Secondary | Urinary tract infection (by performing a urine dipstick test and based on clinical symptoms) | Dipstick: first urine after removal of catheter (group 1: direct after OR, group 2: at least 6 hours after OR), clinical symptoms through study period (up to 6 weeks postoperative) | ||
Secondary | Patient satisfaction (self-administrated questionnaire) | 6 hours postoperative; 24 hours and 6 weeks | ||
Secondary | Visual analogue scale score (VAS score) | 6 hours postoperative; 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03235947 -
Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients
|
Phase 4 | |
Terminated |
NCT02198833 -
Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection
|
N/A | |
Withdrawn |
NCT01881165 -
Cranberry on Urinary Tract Infections
|
Phase 4 | |
Completed |
NCT02357758 -
Effects of Antibiotic Prophylaxis on Recurrent UTI in Children
|
Phase 4 | |
Completed |
NCT01687114 -
Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products
|
N/A | |
Completed |
NCT01391793 -
Corticosteroids for Children With Febrile Urinary Tract Infections
|
Phase 3 | |
Completed |
NCT01219595 -
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
|
N/A | |
Completed |
NCT00365430 -
SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes
|
N/A | |
Recruiting |
NCT04502095 -
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
|
Phase 4 | |
Completed |
NCT00976963 -
Single Dose Monurol for Treatment of Acute Cystitis
|
N/A | |
Recruiting |
NCT02568800 -
Prolonged Infusion Cefepime and Nosocomial Infections
|
Phase 3 | |
Completed |
NCT02785445 -
Healthy.io Method Comparison & User Performance Study
|
N/A | |
Completed |
NCT02216253 -
L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
|
N/A | |
Completed |
NCT01478620 -
Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)
|
Phase 3 | |
Completed |
NCT01054690 -
Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)
|
N/A | |
Completed |
NCT00371631 -
Colonizing Neurogenic Bladders With Benign Flora
|
Phase 1 | |
Terminated |
NCT03697993 -
Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)
|
Phase 4 | |
Terminated |
NCT01803919 -
Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients
|
N/A | |
Enrolling by invitation |
NCT01231737 -
Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)
|
Phase 2 | |
Completed |
NCT01763008 -
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
|
Phase 4 |